Los medicamentos y la información: implicaciones para la imputación de la responsabilidad civil por riesgo de desarrollo en Colombia
Abstract With the use of a dogmatic test as the methodological design of civil liability and the Consumer Right, the objective was aimed at verifying that the emergence of the special assumption of producer’s responsibility helps strengthen patients’ protection if the proposed possibility of medicat...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artículo |
| Idioma: | Castellano |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://dialnet.unirioja.es/servlet/oaiart?codigo=6522551 |
| Fuente: | Criminalidad, ISSN 1794-3108, Vol. 60, Nº. 1, 2018, pags. 79-93 |
| Etiquetas: |
Añadir etiqueta
Sin etiquetas: Sea el primero en etiquetar este registro
|
| Sumario: |
Abstract With the use of a dogmatic test as the methodological design of civil liability and the Consumer Right, the objective was aimed at verifying that the emergence of the special assumption of producer’s responsibility helps strengthen patients’ protection if the proposed possibility of medications, as inherently risky products, can contribute to harm those expected to consume them. The problem stands out with respect to drugs the adverse effects of which are revealed subsequently to their introduction in the market, which gives rise to the dilemma of deciding whether their adverse effects are revealed after their introduction in the market, which gives rise to the dilemma of whether the liability can be imputed to the faulty medication producer, understood as the research or investigation question. As a result, it was found that, indeed, articulating an interpretation in that sense is viable under the consumer’s protection right in Colombia, where there is an imputation of liability for damages deriving from the defectiveness including the absence of information. |
|---|